2017 SPEAKERS

Nusrat Ali, Principal Scientist of Pharmacovigilance and Risk Management, Sunovion Pharmaceuticals Inc

Laurie Anderson, Director - Safety Evaluation and Risk Management, GlaxoSmithKline

Lawrence Anochie, Senior Manager of Pharmacovigilance, Arbor Pharmaceuticals Llc

Lawrence Anochie at World Drug Safety Americas 2017

Nicole Baker, Director Drug Safety and EEA-QPPV, BioClinica

Dr David Balderson, Global Vice President Safety Operations, Sciformix

Dr David Balderson at World Drug Safety Americas 2017

Greg Ball, Principal Statistician, Merck & Co.

Dr Khaudeja Bano, Safety Medical Director, Abbvie

Arvind Bellur, Director, Head of Safety Data Management, Sanofi Inc

Arvind Bellur at World Drug Safety Americas 2017

Paul Beninger, Director, MD/MBA Program, Tufts University

Andrea Best, Executive Medical Director, Pharmacovigilance and Patient Safety, AbbVie

Dr William Bleker, Senior Director, PV & Safety Risk Management, Mirati Therapeutics, Inc.

Mariette Boerstoel-Streefland, Head Global Safety and Pharmacovigilance, Baxalta

Mariette Boerstoel-Streefland at World Drug Safety Americas 2017

Wenda Brennen, Head of Pharmacovigilance Services, PharmaLex

Christina Budzynski, Director, Global Integration & Delivery in Global Pharmacovigilance, Otsuka America Pharmaceutical, Inc.

Stephen Charles Schmidt, Project Manager, Aris Global

Stephen Charles Schmidt at World Drug Safety Americas 2017

Susan Colilla, Senior Director of Pharmacoepidemiology, Global Epidemiology & Pharmacovigilance, Sanofi

Shaun Comfort, Assoc Director of Risk Management, Genentech A Member of the Roche Group

Esther De La Cuesta, Global Safety Lead, Senior Medical Director Clinical Science R&D Marketed Products Group, Takeda

Cecilio Delgra, Associate Vice President Global Clinical Safety & Pharmacovigilance Head, Medical Safety Review and CT Safety Reporting, Merck

Steve Dingman, Senior Medical Director, Global Pharmacovigilance, AbbVie

Steve Dingman at World Drug Safety Americas 2017

James Duhig, Director Behavioral Sciences, AbbVie

James Duhig at World Drug Safety Americas 2017

Thomas Felix, Medical Director, R&D Policy, Intercontinental Region, Amgen

Sarah Frise, Director Risk Management, AstraZeneca

Amrit Gill, Director-Pharmacovigilance & Risk Management, Dr Reddy's Laboratories Inc

Nicole Gillen, Senior Marketing Director, ArisGlobal

Nicole Gillen at World Drug Safety Americas 2017

Andres Gomez, Head of Epidemiology and Signal Detection and Data Management, Bristol Myers Squibb

Andres Gomez at World Drug Safety Americas 2017

Neal Grabowski, Signal Management Officer Global Patient Safety & Labeling, Amgen

William W. Gregory, Senior Director , Safety & Risk Management, Pfizer

William W. Gregory at World Drug Safety Americas 2017

Shahida Hasan, Associate Director-Clinical PV-NA, Dr Reddy's Laboratories

Shahida Hasan at World Drug Safety Americas 2017

Dr Philip Hewitt, Global Head of early Non Clinical Safety, Merck KGaA

Dawn Hill, Senior Manager of Drug Safety and Public Health, Gilead Sciences

Dawn Hill at World Drug Safety Americas 2017

Frank Hong, Executive Director, Drug Safety and Epidemiology, Novartis

Frank Hong at World Drug Safety Americas 2017

Dr Priya Jain, Medical Director, Alkermes

Jeremy Jokinen, Senior Director, Safety Decision Analytics, AbbVie

Jeremy Jokinen at World Drug Safety Americas 2017

Juhaeri Juhaeri, VP and Head, Global Safety Sciences, Sanofi

Hyun Jung Kim, Assistant Professor, The University of Texas At Austin

Robert Kane, Vice President & U.S Head, Life Science Industries, Tata Consultancy Services

Neal Katz, Director of Solutions Marketing, Elsevier

Alex Kim, Safety DM, Mitsubishi Tanabe Pharma Development America

Alex Kim at World Drug Safety Americas 2017

Bill Kivett, Director of Product Management for ProQuest Dialog and Pi2, ProQuest

Joash Krishna, Senior Safety Scientist, PRA Health Sciences

Eileen Leonard, Executive Director, Global Pharmacovigilance and Epidemiology, Bristol Myers Squibb

Eileen Leonard at World Drug Safety Americas 2017

Dr Fabio Lievano, Vice President Safety Sciences, Medical Safety Evaluation, Abbvie Pharmaceuticals Inc

Ben locwin, President, Healthcare Science Advisors

Dr Martha Lundberg, NIH Program Director, National Institutes of Health (NIH)

Michael Lusiola, Director, Patient Safety, AstraZeneca Plc

Marilyn Metcalf, Head, Centre of Innovation, Global MedicalHead, Centre of Innovation, Global Medical, Glaxo Smith Kline

Raj More, Chief Executive Officer, Rxlogix

Raj More at World Drug Safety Americas 2017

Barbara Morollo, Senior Director of Pharmacovigilance and Risk Management, bluebird bio

Barbara Morollo at World Drug Safety Americas 2017

Margaret Nagle, PV Operations, Dr Reddy's Laboratories

Margaret Nagle at World Drug Safety Americas 2017

William O'Brien, Chairman of Medical Surveillance Team and Virology, Global Pharmacovigilance and Epidemiology, Bristol Myers Squibb

William O'Brien at World Drug Safety Americas 2017

Bruce Palsulich, Vice President of Product Strategy, Oracle Health Sciences

Urvi Patel, Pharmacy Fellow, Dr Reddy's Laboratories

Urvi Patel at World Drug Safety Americas 2017

Mansi Patel, Pharmaceutical Associate, Charotar University of Science and Technology

Carrie Pierce, Senior Project Manager, Epidemico

Jamie Portnoff, Vice President and Global Head of the Business Transformation Practice, Foresight Group International AG

John Price, MD Executive Director of Risk Management and GPV, Alexion Pharmaceuticals

John Price at World Drug Safety Americas 2017

Daniel Reshef, Group Medical Director, Bristol Myers Squibb

Daniel Reshef at World Drug Safety Americas 2017

Theresa Robertson, Director, Pharmacovigilance Operations, Ariad Pharmaceuticals

Theresa Robertson at World Drug Safety Americas 2017

Inez Ruiz White, Associate Director, GPV Medical Safety (Risk Evaluation & Reporting), Otsuka Pharmaceutical Inc

Inez Ruiz White at World Drug Safety Americas 2017

Andrew Rut, CEO and Founder, MyMeds&Me

Maribel Salas, Senior Principal Scientist Medical Director, Merck and Co Inc

Laura Salomon, Associate Director of Medical Safety Operations, Otsuka Pharmaceutical Companies

Laura Salomon at World Drug Safety Americas 2017

Selena Scaglione, Senior Manager, Drug Safety & Public Health, Gilead Sciences

Sundeep Sethi, Vice President, Safety Operations, Abbvie

Neha Sheth, PhD, PharmD, Global Head, Risk Management, Astellas

Barbara Silva-Tillmann, Senior Medical Director, Benefit Risk Management, Abbvie

Yuliya Skorina, Associate Safety Physician, AstraZeneca

Yuliya Skorina at World Drug Safety Americas 2017

Ellen Snyder, Senior Biometrician, Clinical Safety Statistics, Merck

Ellen Snyder at World Drug Safety Americas 2017

Manu Sondhi, Senior Director, Novartis

Jeff Southwood, Director of Product Development, Adis Insight

Walter Straus, Executive Director and Head, Scientific Affairs/ Vaccines, Merck And Company

Walter Straus, Associate Vice President and Therapeutic Area Head of Clinical Safety and Risk Management, Merck & Co.

Walter Straus at World Drug Safety Americas 2017

Carmit Strauss, Risk Management, Amgen

Carmit Strauss at World Drug Safety Americas 2017

Veronica Urdaneta, Senior Principal Scientist/ Physician, Merck

Veronica Urdaneta at World Drug Safety Americas 2017

George Van Baelen, Head Pharmacovigilance Latin America & Caribbean, Baxalta Inc

Leonardo Viana Nicacio, Senior Global Medical Affairs Leader, AstraZeneca

Leonardo Viana Nicacio at World Drug Safety Americas 2017

Ekaterina Walker, Medical Director, Purdue Pharma

Ekaterina Walker at World Drug Safety Americas 2017

William Wang, Executive Director, Clinical Safety Statistics, Merck

William Wang at World Drug Safety Americas 2017

Susan Welsh, Former Chief Safety Officer, Sanofi

Susan Welsh at World Drug Safety Americas 2017

Joseph Wong, Manager, Pharmacovigilance, Horizon Pharma Plc

Joseph Wong at World Drug Safety Americas 2017

sammy Yuan, Statistician, Merck

Angang Zhang, Senior Scientist, Biostatistics, Clinical Safety Statistics, Merck

Xiaofeng Zhou, Senior Director, Epidemiology | Worldwide Safety and Regulatory, Pfizer

Hao Zhu, Associate Professor, Rutgers University